“Air Force intelligence components do not engage in experimentation involving human subjects for intelligence purposes,” a new Air Force Instruction (pdf) states categorically.
Except for the exceptions.
“Any exception would require approval by the Secretary or Under Secretary of the Air Force and would be undertaken only with the informed consent of the subject and in accordance with procedures established by AF/SG to safeguard the welfare of subjects.”
The new Instruction presents a generally scrupulous account of the regulatory framework within which Air Force intelligence operates. It addresses domestic search and surveillance, imagery collection and dissemination, mail covers, and other intelligence activities.
See Air Force Instruction 14-104, “Oversight of Intelligence Activities,” 16 April 2007.
Some other noteworthy new Air Force Instructions include these (both pdf):
AFI 10-2604, “Disease Containment Planning Guidance,” 6 April 2007.
AFI 40-201, “Managing Radioactive Materials in the U.S. Air Force,” 13 April 2007.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.